Pression
Coatesville, US · Founded 2019 · Pennsylvania LLC · 1 known investors
Find your way into Pression
Sign up to find every way you can get introduced to Pression
- Your email: who you already know at Pression, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pression team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Pression LLC develops Wave PRO, a non-invasive external counterpulsation (ECP) therapy device using lightweight calf sleeves for adults with Chronic Stable Angina who are not candidates for revascularization. The device is aimed at clinics and hospitals, using fingertip PPG sensing and automated timing to deliver ECP therapy with reduced setup time and minimal staff involvement.
Founders & leadership
AS
Adam SalamonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 2 rounds · 2021
▶$2.5MraisedDec 2024 · 18 investors · Other Health CareRule 506(b)
▶$2.5MraisedDec 2024 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam SalamonExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Dec 2021
- Incorporated
- Limited Liability Company, Pennsylvania, 2019
- Federal exemptions
- 06b
▶$370KraisedMar 2021 · 8 investors · Other Health CareRule 506(b)
▶$370KraisedMar 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Adam SalamonExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $370K
- Minimum investment
- $10K
- Proceeds to insiders
- $30K
- First sale
- Mar 2021
- Incorporated
- Limited Liability Company, Pennsylvania, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Pression do?
- Pression LLC develops Wave PRO, a non-invasive external counterpulsation (ECP) therapy device using lightweight calf sleeves for adults with Chronic Stable Angina who are not candidates for revascularization. The device is aimed at clinics and hospitals, using fingertip PPG sensing and automated timing to deliver ECP therapy with reduced setup time and minimal staff involvement.
- Who are Pression's investors?
- Pression's investors include NextFab Ventures.
- How much funding has Pression raised?
- Pression has disclosed $2.9M raised across 2 rounds.
- Where is Pression headquartered?
- Pression is headquartered in Coatesville, US.